Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | PPARG | P37231 | 5/20 | 0.67 |
| ▸ | PPARD | Q03181 | 4/20 | 0.67 |
| ▸ | PPARA | Q07869 | 4/20 | 0.67 |
| ▸ | TERT | O14746 | 3/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.67 |
| ▸ | BLM | P54132 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | FABP4 | P15090 | 3/20 | 0.67 |
| ▸ | USP2 | O75604 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.67 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | F7 | P08709 | 2/20 | 0.67 |
| ▸ | F3 | P13726 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29497770 | 1.00 | TOP1 (0.70) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL3750682 | 0.93 | MAPT (0.77) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL15808604 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL2228910 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL15287028 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL2566928 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL55116 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL2228907 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL3679458 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA | |
| SCHEMBL3507735 | 0.91 | MAPT (0.75) | TOP1MAPTPPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11135187-B2 | Compositions and methods for treating diabetic retinopathy | NATIONAL INSTITUTES OF HEALTH (NIH) (US) | 2021-10-05 | — | — | US | claimed |
| US-20090069418-A1 | Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-03-12 | — | — | US | claimed |
| US-20230123863-A1 | A GLIA CELL AND NEURON CO-CULTURE SYSTEM AND METHOD | UNIV NAT YANG MING (TW) | 2023-04-20 | — | — | US | disclosed |
| WO-2022005463-A1 | A GLIA CELL AND NEURON CO-CULTURE SYSTEM AND METHOD | NATIONAL YANG-MING UNIVERSITY (TW) | 2022-01-06 | — | — | WO | disclosed |
| US-11135187-B2 | Compositions and methods for treating diabetic retinopathy | NATIONAL INSTITUTES OF HEALTH (NIH) (US) | 2021-10-05 | — | — | US | disclosed |
| US-20090069418-A1 | Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-03-12 | — | — | US | disclosed |
| US-20080095711-A1 | Modulators of Pulmonary Hypertension | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-04-24 | — | — | US | disclosed |
| US-20080095711-A1 | Modulators of Pulmonary Hypertension | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-04-24 | — | — | US | disclosed |
| US-20080095711-A1 | Modulators of Pulmonary Hypertension | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080095711-A1 | Modulators of Pulmonary Hypertension | HIF1AN, PTGIS, PTGIR | TOP1 4192/4885MAPT 4856/4885PPARG 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.